2022
Abnormal left atrial body stiffness is predicted by appendage size: impact of appendage occlusion on left atrial mechanics assessed by pressure-volume analysis
Bregasi A, Freeman JV, Curtis JP, Akar JG, Ortiz-Leon XA, Maia JH, Higgins AY, Matthews RV, Sinusas AJ, McNamara RL, Sugeng L, Lin BA. Abnormal left atrial body stiffness is predicted by appendage size: impact of appendage occlusion on left atrial mechanics assessed by pressure-volume analysis. AJP Heart And Circulatory Physiology 2022, 323: h559-h568. PMID: 35960632, PMCID: PMC9576173, DOI: 10.1152/ajpheart.00083.2022.Peer-Reviewed Original ResearchMeSH KeywordsAtrial AppendageAtrial FibrillationCardiac CatheterizationEchocardiography, TransesophagealHumansStrokeTreatment OutcomeVascular DiseasesConceptsLeft atrial appendage occlusionLA stiffnessAppendage occlusionLA appendageLA mechanicsTransesophageal echocardiographyPressure-volume analysisPercutaneous left atrial appendage occlusionAdverse atrial remodelingAtrial appendage occlusionLeft atrial appendageLA volume measurementsAtrial cardiomyopathyBaseline characteristicsLA complianceAtrial remodelingClinical outcomesAtrial appendageAtrial mechanicsCardiac performancePathophysiological roleBaseline parametersMagnitude of increaseAppendage sizeOcclusion
2019
Patient, clinician and logistic barriers to blood pressure control among adult hypertensives in rural district hospitals in Rwanda: a cross-sectional study
Sibomana J, McNamara R, Walker T. Patient, clinician and logistic barriers to blood pressure control among adult hypertensives in rural district hospitals in Rwanda: a cross-sectional study. BMC Cardiovascular Disorders 2019, 19: 231. PMID: 31638907, PMCID: PMC6805529, DOI: 10.1186/s12872-019-1203-3.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAntihypertensive AgentsBlood PressureClinical CompetenceCross-Sectional StudiesFemaleGuideline AdherenceHospitals, RuralHumansHypertensionMaleMedication AdherenceMiddle AgedPhysician's RolePractice Guidelines as TopicPractice Patterns, Physicians'RwandaTime FactorsTreatment OutcomeYoung AdultConceptsRural district hospitalDistrict hospitalsBlood pressure controlBarriers to effective blood pressure controlRural Rwandan district hospitalsAssociated with poor blood pressure controlRwandan district hospitalsBarriers to blood pressure controlPoor blood pressure controlMethodsThis cross-sectionalCross-sectional studyLogistical factorsMedication side effectsPressure controlAnti-hypertensive medicationsHypertensive patientsSociodemographic factorsBlood pressureBlood pressure dataPrescribed medicationsEffective blood pressure controlJNC 8 recommendationsGoal blood pressurePatient factorsMedical costs
2015
Standardized Outcome Measurement for Patients With Coronary Artery Disease: Consensus From the International Consortium for Health Outcomes Measurement (ICHOM)
McNamara RL, Spatz ES, Kelley TA, Stowell CJ, Beltrame J, Heidenreich P, Tresserras R, Jernberg T, Chua T, Morgan L, Panigrahi B, Rosas Ruiz A, Rumsfeld JS, Sadwin L, Schoeberl M, Shahian D, Weston C, Yeh R, Lewin J. Standardized Outcome Measurement for Patients With Coronary Artery Disease: Consensus From the International Consortium for Health Outcomes Measurement (ICHOM). Journal Of The American Heart Association 2015, 4: e001767. PMID: 25991011, PMCID: PMC4599409, DOI: 10.1161/jaha.115.001767.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionHealth Outcomes MeasurementOutcome measurementsMyocardial infarctionCoronary artery disease outcomesPatient-reported health statusCoronary artery bypassPercutaneous coronary interventionCoronary artery diseasePatient-centered outcomesStandardized outcome measurementsLongitudinal outcomesCardiovascular hospital admissionsAsymptomatic CADAcute complicationsArtery bypassCoronary interventionRenal failureArtery diseaseHospital admissionInternational Working GroupRisk factorsCardiovascular diseaseDisease outcomeOutcome measures
2000
Management of new onset atrial fibrillation.
McNamara R, Bass E, Miller M, Segal J, Goodman S, Kim N, Robinson K, Powe N. Management of new onset atrial fibrillation. Evidence Report Technology Assessment 2000, 1-7. PMID: 11471248, PMCID: PMC4781222.Peer-Reviewed Original ResearchAdultAge DistributionAgedAged, 80 and overAmbulatory CareAnti-Arrhythmia AgentsAnticoagulantsAspirinAtrial FibrillationClinical Trials as TopicComorbidityDecision Support TechniquesEchocardiographyElectric CountershockEvidence-Based MedicineFemaleHumansIncidenceMaleMiddle AgedPrognosisRisk FactorsSex DistributionSurvival RateThromboembolismTreatment OutcomePrevention of Thromboembolism in Atrial Fibrillation
Segal J, McNamara R, Miller M, Kim N, Goodman S, Powe N, Robinson K, Bass E, Center F. Prevention of Thromboembolism in Atrial Fibrillation. Journal Of General Internal Medicine 2000, 15: 56-67. PMID: 10632835, PMCID: PMC1495320, DOI: 10.1046/j.1525-1497.2000.04329.x.Peer-Reviewed Original ResearchConceptsAtrial fibrillationMajor bleedsStroke preventionMajor hemorrhageCochrane Collaboration's CENTRAL databaseAdditional major bleedsMore major bleedingMore major bleedsMore major hemorrhagePrimary stroke preventionPrevention of thromboembolismRisk of hemorrhageTrials of drugsCentral databaseMajor bleedingYounger patientsPrimary preventionMean agePatient riskBaseline riskStroke rateLower riskAspirinPatientsModerate evidenceThe evidence regarding the drugs used for ventricular rate control.
Segal J, McNamara R, Miller M, Kim N, Goodman S, Powe N, Robinson K, Yu D, Bass E. The evidence regarding the drugs used for ventricular rate control. The Journal Of Family Practice 2000, 49: 47-59. PMID: 10678340.Peer-Reviewed Original ResearchConceptsHeart rate controlExercise toleranceAtrial fibrillationHeart rateBetter heart rate controlCochrane Collaboration's CENTRAL databaseCalcium channel blocker verapamilAbstracts of trialsTrial of verapamilImproved exercise toleranceVentricular rate controlTrials of drugsEnglish-language articlesEnglish-language abstractsCentral databaseVentricular rateBlocker verapamilInsufficient evidenceSystematic reviewPlaceboFibrillationTrialsDrugsLanguage publicationsPatients